Topic

Novartis

European shares muted as oil rally fuels caution

Published 09 Sep, 2026 05:39am

FRANKFURT: European shares were little changed on Tuesday as escalating tensions in the Middle East and rising oil...

European shares subdued as surging crude sharpens focus on ECB rate path

Published 08 Sep, 2026 06:01am

FRANKFURT: European shares closed flat on Monday as rising oil prices following renewed US-Iran tensions fuelled...

Novartis pauses autoimmune cell therapy studies after deaths, WSJ reports

Published 01 Sep, 2026 11:31am

The experimental treatment is called chimeric antigen receptor T-cell, or CAR-T

Novartis profit beat driven by cost control as patent expiries bite

Published 21 Jul, 2026 04:57pm

Sales of the heart drug fell 50% to $1.18 billion

Novartis Q2 profit up as generic competition mounts

Published 21 Jul, 2026 11:27am

The Swiss drugmaker saw quarterly group operating income, adjusted for special items

Novartis Q1 profit down on US generic erosion

Published 28 Apr, 2026 10:13am

Quarterly group operating income, adjusted for special items, came in at $4.9 billion

Novartis to exit Indian unit in $159 million deal

Published 20 Feb, 2026 10:01am

The stake will be acquired by a consortium of WaveRise Investments, ChrysCapital and Two Infinity Partners

Drugmakers brace for Europe pricing fight after Trump’s US price-cut deals

Updated 09 Jan, 2026 08:17am

Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after...

Drugmakers raise US prices on 350 medicines despite pressure from Trump

Published 01 Jan, 2026 07:36am

Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and...

ICI Pakistan, now LCI, rejects claims of exiting pharma manufacturing

Published 26 Nov, 2025 10:15am

Pharmaceutical business continues to grow, says the company

EDITORIAL: Exit of MNCs

Updated 25 Nov, 2025 08:06am

EDITORIAL: According to a Business Recorder exclusive, the government is considering the introduction of investment...

Phase-I assessment over: CCP clears IIL’s takeover of Novartis

Published 09 Nov, 2025 03:22am

ISLAMABAD: The Competition Commission of Pakistan (CCP) has authorized the acquisition of Novartis Pharma (Pakistan)...

Novartis Q3 operating income up 6% on new drug sales

Published 28 Oct, 2025 11:29am

FRANKFURT: Swiss drugmaker Novartis, on a deal-making spree this year, reported a gain in operating income of 6% as...

Novartis to acquire Tourmaline Bio for $1.4 billion

Published 09 Sep, 2025 12:53pm

BERLIN: Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company...

Novartis slightly raises 2025 earnings forecast, citing strong Q2

Published 17 Jul, 2025 11:12am

BERLIN: Novartis on Thursday posted a slightly more optimistic full-year earnings forecast, citing the strong growth...

Novartis gets approval for first malaria drug for babies and children

Published 08 Jul, 2025 11:50am

ZURICH: Novartis on Tuesday said it had received approval in Switzerland for Coartem, which it said was the first...

Novartis more upbeat on 2025 guidance after strong Q1 momentum

Published 29 Apr, 2025 11:18am

FRANKFURT: Novartis on Tuesday issued a more optimistic full-year earnings guidance, citing strong growth of drugs...

Novartis agrees to acquire Anthos for up to $3.1 billion

Published 11 Feb, 2025 12:13pm

Swiss pharmaceutical giant Novartis said on Tuesday it has agreed to acquire biopharma firm Anthos Therapeutics for...

Novartis raises annual sales guidance until 2028

Published 21 Nov, 2024 11:21am

FRANKFURT: Novartis on Thursday raised its medium-term sales guidance, predicting 6% annual growth through 2028,...

Novartis lifts 2024 guidance for third time on wider use of its drugs

Published 29 Oct, 2024 12:34pm

FRANKFURT: Swiss drugmaker Novartis raised its 2024 earnings guidance for the third time on Tuesday, driven by wider...

Sanofi MS drug tolebrutinib misses goal in relapsing disease trials

Published 02 Sep, 2024 12:36pm

Sanofi’s most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to...

Novartis aims for 5% annual sales growth through 2027

Published 28 Nov, 2023 12:50pm

FRANKFURT: Novartis said it was targeting annual sales growth of 5% per year until 2027 and a core operating income...

Novartis to buy Chinook for up to $3.5bn in boost to late-stage pipeline

Published 19 Jun, 2023 06:54am

BERN: Novartis has agreed to acquire Seattle-based biotech firm Chinook Therapeutics for up to $3.5 billion to boost...

Novartis raises year forecast after sales boost

Published 25 Apr, 2023 12:45pm

ZURICH: Pharmaceutical giant Novartis said Tuesday it was increasing its full-year sales and profits outlook after...

Novartis net profit down in Q3 amid restructuring

Published 25 Oct, 2022 01:02pm

ZURICH: Swiss pharmaceutical giant Novartis on Tuesday reported a sharp drop in net profits in the third quarter,...

Novartis to save at least $1bn by 2024 thanks to simplified structure

Published 04 Apr, 2022 12:47pm

ZURICH: Novartis said on Monday it was integrating its pharmaceuticals and oncology units into an innovative...

Novartis suspends some business activities in Russia

Published 22 Mar, 2022 01:29pm

GENEVA: Swiss drugmaker Novartis said on Tuesday it was suspending capital investments, media advertising, and other...

Novartis Q4 core operating income gains 9%

Published 02 Feb, 2022 11:33am

FRANKFURT: Novartis reported fourth-quarter core operating income gained 9% as higher drug sales offset in increase...

Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners

Published 10 Jan, 2022 12:19pm

ZURICH: Novartis said it will license in a new drug it has been developing with Molecular Partners to treat ...

Novartis sees strong interest in Sandoz generics unit

Published 12 Dec, 2021 04:19am

ZURICH: Novartis is seeing strong interest from private equity investors as well as from other pharmaceuticals...

BR100
BR30
KSE100
KSE30
KMI30

1D 5D 3M 6M 1Y

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / Sep 30	277.31
USD PKR Interbank Buying / Sep 30	277.11
USD to Japanese Yen / Sep 30	157.03
USD to Swiss Franc / Sep 30	0.83
Pound Sterling to USD / Sep 30	1.32
Euro to USD / Sep 30	1.13
SOFR % / Sep 29	3.88

Stock	Volume
S&P 500 / Sep 29	7,670.84
Nasdaq / Sep 29	26,797.54
Dow Jones / Sep 29	51,349.92
India Sensex / Sep 30	72,729.39
Tokyo Nikkei / Sep 30	66,728.56
Hang Seng / Sep 30	24,534.37
FTSE 100 / Sep 30	10,714.17
Germany DAX 30 / Sep 30	25,546.29
France CAC40 / Sep 30	8,055.71

Item	Value
Crude Oil USD/Barrel / Sep 30	89.69
Karachi Cotton PKR/37.32 KG / Sep 30	18,680
Gold 10 Grams PKR / Sep 30	378,631
Gold Spot USD/Ounce / Sep 30	4,309.98
Cotton US¢/pound / Sep 30	79.18
Petrol/Litre / Oct 1	387.40
Diesel/Litre / Oct 1	400.35

Gainers
Losers
Leaders

Stock	Price
Colony Tex.Mills Ltd / Sep 30 Colony Textile Mills Limited(CTM)	7.26 ▲ 1 (15.97%)
Kohinoor Spinning / Sep 30 Kohinoor Spinning Mills Limited(KOSM)	5.73 ▲ 0.77 (15.52%)
Lse Spac-I Ltd. / Sep 30 Lse Spac-I Limited(SPAC1)	20.41 ▲ 1.86 (10.03%)
Tri-Star Mutual / Sep 30 Tri-Star Mutual Fund Limited(TSMF)	16.57 ▲ 1.51 (10.03%)
Sindh Modaraba / Sep 30 Sindh Modaraba(SINDM)	33.28 ▲ 3.03 (10.02%)
Ghazi Fabrics / Sep 30 Ghazi Fabrics International Limited(GFIL)	26.38 ▲ 2.4 (10.01%)
Asim Textile / Sep 30 Asim Textile Mills Limited(ASTM)	113.96 ▲ 10.36 (10%)
Dadex Eternit / Sep 30 Dadex Eternit Limited(DADX)	150.32 ▲ 13.67 (10%)
First Punjab Modaraba / Sep 30 First Punjab Modaraba(FPJM)	29.04 ▲ 2.64 (10%)
Oilboy Energy / Sep 30 Oilboy Energy Limited(OBOY)	18.59 ▲ 1.69 (10%)

Stock	Price
Ashfaq Textile / Sep 30 Ashfaq Textile Mills Limited(ASHT)	50.57 ▼ -5.62 (-10%)
Ghani Chemworld Limited(PRS) / Sep 30 Ghani Chemworld Limited(PRS)(GCWLPRS)	118.83 ▼ -13.16 (-9.97%)
Burj Clean Energy Modaraba / Sep 30 Burj Clean Energy Modaraba(GEM)(GEMBCEM)	11.25 ▼ -1.15 (-9.27%)
The Thal Ind.Corp. / Sep 30 The Thal Industries Corporation Limited(TICL)	918.13 ▼ -92.07 (-9.11%)
Pakistan Services / Sep 30 Pakistan Services Limited(PSEL)	1,019.63 ▼ -99.15 (-8.86%)
Mandviwala / Sep 30 Mandviwala Mauser Plastic Industries(MWMP)	77.07 ▼ -7.14 (-8.48%)
S.G.Power / Sep 30 S.G. Power Limited(SGPL)	23.41 ▼ -1.84 (-7.29%)
D.M. Corporation / Sep 30 D.M. Corporation Limited(DMC)	165.33 ▼ -11.63 (-6.57%)
Cordoba Logistics / Sep 30 Cordoba Logistics & Ventures Limited(CLVL)	28.32 ▼ -1.94 (-6.41%)
EMCO Industries / Sep 30 Emco Industries Limited(EMCO)	32.10 ▼ -1.93 (-5.67%)

Stock	Volume
Pak Int.Bulk / Sep 30 Pakistan International Bulk Terminal(PIBTL)	73,446,994 ▲ 0.11
Kohinoor Spinning / Sep 30 Kohinoor Spinning Mills Limited(KOSM)	58,387,095 ▲ 0.77
Tasdeeq Info. Serv. / Sep 30 Tasdeeq Information Services Limited(TISL)	50,882,891 ▼ -0.09
Cnergyico PK / Sep 30 Cnergyico PK Limited(CNERGY)	28,308,841 ▲ 0.03
D.S. Ind. Ltd. / Sep 30 D.S. Industries Limited(DSIL)	21,823,804 ▲ 1.27
Arif Habib Corp / Sep 30 Arif Habib Corporation Limited(AHCL)	17,873,579 ▲ 0.1
Pak Refinery / Sep 30 Pakistan Refinery Limited(PRL)	17,817,038 ▲ 0.45
WorldCall Telecom / Sep 30 Worldcall Telecom Limited(WTL)	17,431,935 ▼ -0.01
S.G.Power / Sep 30 S.G. Power Limited(SGPL)	16,575,953 ▼ -1.84
F. Nat.Equities / Sep 30 First National Equities Limited(FNEL)	14,238,200 ▲ 0

Novartis

Most Popular